Showing results for 
Search instead for 
Did you mean: 

Future of designer drug analysis: Where are we going with HRAM?

Scientific Advocate II
Scientific Advocate II
Increased designer drug introduction has put more pressure on the law enforcement agencies to quickly identify these compounds. Advancements in the mass spectrometry based assays have helped identify these compounds.
In this webinar Dr. Jean-Claude Alvarez, Professor of Medicine in Pharmacology at the University Versailles Saint Quentin-en-Yvelines explains how he and his team of experts analyze designer drugs in various matrices with MS techniques.
Version history
Last update:
‎11-09-2021 01:55 AM
Updated by: